COMMON STOCK
PARAMOUNT GOLD AND SILVER
CORP.
UNDERWRITING
AGREEMENT
DAHLMAN ROSE
& COMPANY, LLC
BLACKMONT
CAPITAL INC.
c/o Dahlman
Rose & Company, LLC
142 West
57 th
Street
New York, New
York 10019
Paramount Gold and Silver Corp., a corporation
organized and existing under the laws of Delaware (the "
Company "), proposes, subject to the terms and conditions
stated herein, to issue and sell to the several underwriters named
in Schedule I hereto (the " Underwriters ") an aggregate of
16,000,000 shares (the " Firm Shares ") of its
common stock, $0.001 par value per share (the " Common Stock
"), and, for the sole purpose of covering over-allotments in
connection with the sale of the Firm Shares, at the option of the
Underwriters, up to an additional 2,400,000 shares
(the " Additional Shares ") of Common Stock. The
Firm Shares and any Additional Shares purchased by the Underwriters
are referred to herein as the " Shares ". Dahlman
Rose & Company, LLC is acting as lead manager (the " Lead
Manager ") in connection with the offering and sale of the
Shares contemplated herein (the " Offering ").
The Company understands that the Underwriters
propose to make a public offering of the Shares in the United
States and in the Province of Ontario, Canada, either directly or
through their respective U.S. or Canadian broker-dealer affiliates
upon the terms set forth in the Prospectuses (as defined below) as
soon as the Underwriters deem advisable after this Agreement has
been executed and delivered.
1.
Representations and Warranties of the Company
. The Company represents and warrants to, and agrees
with, each of the Underwriters that:
(a) The
Company has filed with the Securities and Exchange Commission (the
" Commission ") a shelf registration statement on Form S-3
(No. 333-153104) relating to the offer and sale, from time to time,
of up to $80,000,000 of the Company's Common Stock and Common
Stock purchase warrants (the initial filing and all pre-effective
amendments thereto collectively being referred to as the "
Initial Registration Statement "); and such Initial
Registration Statement, and any post-effective amendment thereto,
each in the form previously delivered to you, have been declared
effective by the Commission in such form (the base prospectus
filed as part of the Initial Registration Statement, in the form in
which it has been most recently filed with the Commission on or
prior to the date of this Agreement, the " U.S. Base
Prospectus "). All conditions for use of
Form S-3 to register the distribution of the Shares under the
Securities Act of 1933, as amended (the " Securities Act "),
have been satisfied. The various parts of the Initial
Registration Statement, including all exhibits thereto and
including any information in a prospectus or prospectus supplement
relating to the Shares that is filed with the Commission and deemed
or retroactively deemed by virtue of Rule 430B under the Securities
Act to be a part of such registration statement, each as amended at
the time such part of the Initial Registration Statement became
effective under the Securities Act with respect to the
Underwriters, are hereafter collectively referred to as the "
Registration Statement ." Any reference to any
amendment to the Registration Statement shall be deemed to refer to
and include any annual report of the Company filed pursuant to
Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as
amended (the " Exchange Act "), after the effective date of
the Initial Registration Statement that is incorporated by
reference therein. No stop order suspending the
effectiveness of the Initial Registration Statement or any
post-effective amendment thereto has been issued and no proceeding
for that purpose has been initiated or threatened by the
Commission. The prospectus supplement relating to the
Shares, in the form first filed with the Commission pursuant to
Rule 424(b) under the Securities Act, which includes the pricing
information omitted from the U.S. Pricing Prospectus (as defined
below), is hereafter referred to as the " U.S. Prospectus
". Any preliminary prospectus supplement relating to the
Shares filed with the Commission pursuant to Rule 424 under the
Securities Act is hereafter referred to as a " U.S. Preliminary
Prospectus Supplement "; and the U.S. Preliminary Prospectus
Supplement relating to the Shares, as amended or supplemented
immediately prior to the Applicable Time (as defined below), is
hereafter referred to as the " U.S. Pricing Prospectus
".
(b) The
Company is qualified to file a MJDS (as defined below) shelf
prospectus pursuant to the MJDS and has prepared and filed a
preliminary MJDS shelf prospectus dated September 11, 2009 (the "
Canadian Preliminary Base Shelf Prospectus ") and a final
MJDS shelf prospectus dated September 28, 2009 (the "
Canadian Final Base Shelf Prospectus ") providing for the
offer and sale, from time to time, of up to $80,000,000 of the
Company's Common Stock and Common Stock purchase warrants with
the Ontario Securities Commission (the " Canadian
Qualifying Authority "); and a prospectus
receipt (a " Receipt ") has been issued by
the Canadian Qualifying Authority pursuant to the
Securities Act (Ontario) for each of the Canadian
Preliminary Base Shelf Prospectus and the Canadian Final Base Shelf
Prospectus. The term " Canadian Base Prospectus "
means the Canadian Final Base Shelf Prospectus, including documents
incorporated therein by reference, filed in accordance with
the multi-jurisdictional disclosure system described in National
Instrument 71-101 – The Multijurisdictional Disclosure System
of the Canadian Securities Administrators, as amended (the "
MJDS "), the rules and procedures established under all
applicable securities laws in the Province of Ontario and the
respective regulations and rules under such laws together with
applicable published policy statements and instruments of the
Canadian Qualifying Authority (collectively, " Canadian
Securities Laws "). Any preliminary prospectus filed
with the Canadian Qualifying Authority under the MJDS relating to
the Offering is hereinafter referred to as a " Canadian
Preliminary Prospectus Supplement ". The term "
Canadian Pricing Prospectus " means the Canadian Preliminary
Prospectus Supplement relating to the Offering, which excluded
certain pricing information, filed with the Canadian Qualifying
Authority in accordance with the MJDS on October 5, 2009, together
with the Canadian Base Prospectus, including all documents
incorporated therein by reference. The term "
Canadian Prospectus " means the prospectus supplement (the "
Canadian Prospectus Supplement ") relating to the Offering,
which includes the pricing information omitted from the Canadian
Pricing Prospectus, to be dated the date hereof and filed with the
Canadian Qualifying Authority in accordance with the MJDS, together
with the Canadian Base Prospectus, including all documents
incorporated therein by reference. No order suspending
the distribution of the Shares or any other securities of the
Company or preventing or suspending the use of the Canadian Base
Prospectus or any Canadian Preliminary Prospectus Supplement has
been issued by the Canadian Qualifying Authority and no proceedings
for that purpose have been instituted or are pending or, to the
knowledge of the Company, are contemplated by the Canadian
Qualifying Authority, and any request on the part of the Canadian
Qualifying Authority for additional information has been complied
with.
All references
in this Agreement to the Canadian Preliminary Base Shelf
Prospectus, the Canadian Final Base Shelf Prospectus, any
Canadian Preliminary Prospectus Supplement and the Canadian
Prospectus Supplement, or any amendments or supplements to any of
the foregoing, shall be deemed to include any copy thereof filed
with the Canadian Qualifying Authority pursuant to the System for
Electronic Document Analysis and Retrieval (SEDAR).
Any "issuer free writing prospectus" (as defined
in Rule 433 under the Securities Act) relating to the Shares is
hereafter referred to as an " Issuer Free Writing Prospectus
"; and the U.S. Pricing Prospectus, as supplemented by the Issuer
Free Writing Prospectuses, if any, and the information listed in
Annex V hereto, taken together, are hereafter referred to
collectively as the " Pricing Disclosure Package
". Any reference herein to any U.S. Preliminary
Prospectus Supplement, the U.S. Base Prospectus, the U.S. Pricing
Prospectus or the U.S. Prospectus shall be deemed to refer to and
include the documents incorporated by reference therein pursuant to
Item 12 of Form S-3 that were filed under the Exchange Act on or
before the date of such U.S. Preliminary Prospectus Supplement,
U.S. Base Prospectus, U.S. Pricing Prospectus or the U.S.
Prospectus, as the case may be; and any reference herein to any
"amendment" or "supplement" with respect to any U.S. Preliminary
Prospectus Supplement or the U.S. Base Prospectus, the U.S. Pricing
Prospectus or the U.S. Prospectus shall be deemed to refer to and
include (i) the filing of any document under the Exchange Act after
the date of such U.S. Preliminary Prospectus Supplement, U.S. Base
Prospectus, U.S. Pricing Prospectus or the U.S. Prospectus, as the
case may be, which is incorporated therein by reference and (ii)
any such document so filed.
As used herein, " Base Prospectuses "
shall mean, collectively, the Canadian Base Prospectus and the U.S.
Base Prospectus; " Pricing Prospectuses " shall mean,
collectively, the Canadian Pricing Prospectus and the U.S. Pricing
Prospectus; and " Prospectuses " shall mean, collectively,
the Canadian Prospectus and the U.S. Prospectus.
The Company was not an "ineligible issuer" (as
defined in Rule 405 under the Securities Act) as of the eligibility
determination date for purposes of Rules 164 and 433 under the
Securities Act with respect to the Offering contemplated
hereby.
All references in this Agreement to the
Registration Statement, any U.S. Preliminary Prospectus Supplement,
the U.S. Base Prospectus, the U.S. Pricing Prospectus, the U.S.
Prospectus, or any Issuer Free Writing Prospectus, or any
amendments or supplements to any of the foregoing, shall be deemed
to include any copy thereof filed with the Commission pursuant to
its Electronic Data Gathering, Analysis and Retrieval System
(EDGAR).
(c) The
Registration Statement complies, and the U.S. Prospectus and any
further amendments or supplements to the Registration Statement or
the U.S. Prospectus will comply, in all material respects with the
applicable provisions of the Securities Act and the rules and
regulations of the Commission thereunder (the " Rules and
Regulations "); the Registration Statement does not and will
not, as of the applicable effective date as to each part of the
Registration Statement and any amendment thereof or supplement
thereto, contain an untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary in
order to make the statements therein not misleading; the U.S.
Prospectus and any amendment thereof or supplement thereto, as of
the time of filing thereof, as of the Closing Date (as defined
below) and as of the Additional Closing Date (as defined below), if
any, will not contain an untrue statement of a material fact or
omit to state a material fact required to be stated therein or
necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading;
provided, however, that this representation and warranty shall not
apply to any information contained in or omitted from the
Registration Statement or the U.S. Prospectus or any amendment
thereof or supplement thereto in reliance upon and in conformity
with information furnished in writing to the Company by or on
behalf of any Underwriter through the Lead Manager specifically for
use therein. The parties hereto agree that such
information provided by or on behalf of any Underwriter through the
Lead Manager consists solely of the material referred to in Section
16 hereof.
(d) The
Canadian Base Prospectus and the Canadian Pricing Prospectus
complied, and the Canadian Prospectus and any further amendments or
supplements thereto will comply, in all material respects with the
applicable requirements of Canadian Securities Laws; the Canadian
Pricing Prospectus, as of the time of filing thereof, did not, and
the Canadian Prospectus and any further amendments or supplements
thereto will not, as of the time of filing thereof and through the
Closing Date and the Additional Closing Date, if any, include any
untrue statement of a material fact or omit to state a material
fact that is required to be stated or necessary in order to make
the statements therein, in light of the circumstances under which
they were made, not false or misleading; and the Canadian Pricing
Prospectus, as of the time of filing thereof, constituted, and the
Canadian Prospectus and any further amendments or supplements
thereto will, as of the time of filing thereof and through the
Closing Date and the Additional Closing Date, if any, constitute,
full, true and plain disclosure of all material facts relating to
the Shares and to the Company; provided, however, that this
representation and warranty shall not apply to any information
contained in or omitted from the Canadian Pricing Prospectus or the
Canadian Prospectus or any amendment thereof or supplement thereto
in reliance upon and in conformity with information furnished in
writing to the Company by or on behalf of any
Underwriter through the Lead Manager specifically for use
therein. The parties hereto agree that such information
provided by or on behalf of any Underwriter through the Lead
Manager consists solely of the material referred to in Section 16
hereof.
(e) No
order preventing or suspending the use of any U.S. Preliminary
Prospectus, the U.S. Base Prospectus, the U.S. Pricing Prospectus
or any Issuer Free Writing Prospectus has been issued by the
Commission, and each U.S. Preliminary Prospectus Supplement
and the U.S. Pricing Prospectus, at the time of filing thereof,
complied in all material respects with the applicable provisions of
the Securities Act and the Rules and Regulations, and did not
contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which
they were made, not misleading; provided, however, that this
representation and warranty shall not apply to any information
contained in or omitted from any U.S. Preliminary
Prospectus Supplement or the U.S. Pricing Prospectus in
reliance upon and in conformity with information furnished in
writing to the Company by or on behalf of any
Underwriter through the Lead Manager specifically for use
therein. The parties hereto agree that such information
provided by or on behalf of any Underwriter through the Lead
Manager consists solely of the material referred to in Section 16
hereof.
(f) For
purposes of this Agreement, the " Applicable Time " is 5:00
p.m. (New York City time) on October 8, 2009. The
Pricing Disclosure Package, as of the Applicable Time, did not, and
from the Applicable Time through the Closing Date and the
Additional Closing Date, if any, will not, contain an untrue
statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made,
not misleading. Each Issuer Free Writing Prospectus
complies in all material respects with the applicable provisions of
the Securities Act and the Rules and Regulations, and does not
include information that conflicts with the information contained
in the Registration Statement, the Pricing Prospectuses or the
Prospectuses, and any Issuer Free Writing Prospectus, as
supplemented by and taken together with the Pricing Disclosure
Package as of the Applicable Time, did not contain an untrue
statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made,
not misleading. No representation and warranty is made
in this Section 1(f) with respect to any information contained in
or omitted from the Pricing Disclosure Package or any Issuer Free
Writing Prospectus in reliance upon and in conformity with
information furnished in writing to the Company by or on behalf of
any Underwriter through the Lead Manager specifically for use
therein. The parties hereto agree that such information
provided by or on behalf of any Underwriter through the Lead
Manager consists solely of the material referred to in Section 16
hereof.
(g) The
documents incorporated or deemed to be incorporated by reference in
the Pricing Prospectuses and the Prospectuses, at the time they
were or hereafter are filed with the Commission or the Canadian
Qualifying Authority, as applicable, complied and will comply in
all material respects with the requirements of the Securities Act,
the Exchange Act, the Rules and Regulations and Canadian Securities
Laws, as applicable, and, when read together with the other
information in the Pricing Prospectuses and the Prospectuses, as
applicable, do not contain an untrue statement of a material fact
or omit to state a material fact required to be stated therein or
necessary to make the statements therein, in the light of the
circumstances under which they were made, not
misleading.
(h) HLB
Cinnamon Jang Willoughby & Company, who have audited the
consolidated financial statements and supporting schedules and
information of the Company and its subsidiaries (each, a "
Subsidiary " and, collectively, the " Subsidiaries ")
that are included or incorporated by reference in the Registration
Statement, the Pricing Prospectuses and the Prospectuses, and
whose reports appear or are incorporated by reference in the
Registration Statement, the Pricing Prospectuses and the
Prospectuses are independent with respect to the Company as
required by Canadian Securities Laws and are independent registered
public accountants as required by the Securities Act, the Rules and
Regulations, and the Exchange Act.
(i) Subsequent
to the respective dates as of which information is given in the
Registration Statement, the Pricing Prospectuses and the
Prospectuses, except as disclosed in the Pricing Prospectuses and
the Prospectuses, (i) the Company has not declared or paid any
dividends, or made any other distribution of any kind, on or in
respect of its capital stock, (ii) there has not been any material
change in the capital stock or long-term debt of the Company or any
of its subsidiaries, (iii) neither the Company nor any Subsidiary
has sustained any material loss or interference with its business
or properties from fire, explosion, flood, hurricane, accident or
other calamity, whether or not covered by insurance, or from any
labor dispute or any legal or governmental proceeding, and (iv)
there has not been any material adverse change or any development
reasonably likely to result in a material adverse change, whether
or not arising from transactions in the ordinary course of
business, in or affecting the business, management, condition
(financial or otherwise), results of operations, properties or
prospects of the Company and the Subsidiaries, taken as a
whole. Since the date of the latest balance sheet
included, or incorporated by reference, in the Registration
Statement, the Pricing Prospectuses and the Prospectuses, neither
the Company nor any Subsidiary has incurred or undertaken any
liabilities or obligations, whether direct or indirect, liquidated
or contingent, matured or unmatured, or entered into any
transactions, including any acquisition or disposition of any
business or asset, which are material to the Company and the
Subsidiaries, taken as a whole, except for liabilities, obligations
and transactions which are disclosed in the Pricing Prospectuses
and the Prospectuses.
(j) No
Subsidiary is currently prohibited, directly or indirectly, from
paying any dividends to the Company, from making any other
distribution on such Subsidiary's capital stock, from repaying to
the Company any loans or advances to such Subsidiary from the
Company or from transferring any of such Subsidiary's property or
assets to the Company or any other Subsidiary of the
Company.
(k) The
Company has an authorized and outstanding capitalization as set
forth in the Pricing Prospectuses and the Prospectuses, and all of
the issued and outstanding shares of capital stock of the Company
are fully paid and non-assessable and have been duly and validly
authorized and issued, in compliance with all applicable state,
U.S. federal and Canadian securities laws and not in violation of
or subject to any preemptive or similar right that entitles any
person to acquire from the Company or any Subsidiary any Common
Stock or other security of the Company or any security convertible
into, or exercisable or exchangeable for, Common Stock or any other
such security (any " Relevant Security "), except for such
rights as may have been fully satisfied or waived prior to the
effectiveness of the Registration Statement. The Company's
direct or indirect percentage ownership of the shares of the
Subsidiaries is accurately disclosed in Exhibit A
hereto. All of the issued shares of capital stock of or
other ownership interests in each Subsidiary have been duly
and validly authorized and issued and are fully paid and
non-assessable and (except for directors' qualifying shares and as
otherwise set forth in the Pricing Prospectuses and the
Prospectuses) are owned directly or indirectly by the Company free
and clear of any lien, charge, mortgage, pledge, security interest,
claim, equity, trust or other encumbrance, preferential
arrangement, defect or restriction of any kind whatsoever (any "
Lien ").
(l) The
Company has full power and authority (corporate or otherwise) to
issue the Shares and to perform its obligations
hereunder. The Shares to be delivered on the Closing
Date and the Additional Closing Date, if any, have been duly and
validly authorized and, when issued and delivered in accordance
with this Agreement, will be duly and validly issued, fully paid
and non-assessable, will have been issued in
compliance with all applicable state, U.S. federal and Canadian
securities laws and will not have been issued in violation of or
subject to any preemptive or similar right that entitles any person
to acquire any Relevant Security from the Company. The
Common Stock and the Shares conform to the descriptions thereof
contained in the Registration Statement, the Pricing Prospectuses
and the Prospectuses. Except as disclosed in the Pricing
Prospectuses and the Prospectuses, the Company has no outstanding
warrants, options to purchase, or any preemptive rights or other
rights to subscribe for or to purchase, or any contracts or
commitments to issue or sell, any Relevant
Security. Except as disclosed in the Pricing
Prospectuses and the Prospectuses, no holder of any Relevant
Security has any rights to require registration or qualification
under the Securities Act or the Canadian Securities Laws of any
Relevant Security in connection with the offer and sale of the
Shares contemplated hereby, and any such rights so disclosed have
either been fully complied with by the Company or effectively
waived by the holders thereof.
(m) The Subsidiaries
listed in Exhibit A hereto are the only subsidiaries of the Company
(within the meaning of Rule 405 under the Securities
Act). Each of the Company and each Subsidiary has
been duly organized and validly exists as a corporation,
partnership or limited liability company in good standing under the
laws of its jurisdiction of organization. Each of the
Company and each Subsidiary is duly qualified to do business and is
in good standing as a foreign corporation, partnership or limited
liability company in each jurisdiction in which the character or
location of its properties (owned, leased or licensed) or the
nature or conduct of its business makes such qualification
necessary, except for those failures to be so qualified or in good
standing which (individually and in the aggregate) could not
reasonably be expected to have a material adverse effect on (i) the
business, management, condition (financial or otherwise), results
of operations, properties or prospects of the Company and the
Subsidiaries, taken as a whole, or (ii) the ability of the Company
to consummate the Offering or any other transaction contemplated by
this Agreement (a " Material Adverse Effect
").
(n) The
Company and each Subsidiary has all requisite power and
authority, and, except as disclosed in the Registration Statement,
the Pricing Prospectus and the Prospectuses, all necessary
consents, approvals, authorizations, orders, registrations,
qualifications, licenses, filings and permits of, with and from all
judicial, regulatory and other legal or governmental agencies and
bodies and all third parties, U.S., Canadian or foreign
(collectively, the " Consents "), to own, lease and operate
its properties and conduct its business as it is now being
conducted and as disclosed in the Registration Statement,
the Pricing Prospectuses and the Prospectuses, and each such
Consent is valid and in full force and effect, except in each case
as could not reasonably be expected to have a Material Adverse
Effect. Neither the Company nor any Subsidiary has
received notice of any investigation or proceedings which, if
decided adversely to the Company or any such Subsidiary, could
reasonably be expected to result in a Material
Adverse Effect. The Company and the Subsidiaries are not aware
of any pending change or contemplated change to any applicable law
or regulation or governmental position that could reasonably be
expected to result in a Material Adverse Effect.
(o) This
Agreement has been duly and validly authorized, executed and
delivered by the Company.
(p) There
are no reports or information that in accordance with the
requirements of Canadian Securities Laws must be made publicly
available in connection with the Offering of the Shares that have
not been made publicly available as required; there are no
documents required to be filed as of the date hereof with the
Canadian Qualifying Authority or with any other Canadian securities
regulatory authority in connection with the Offering of the Shares
that have not been filed as required; the Company has not filed any
confidential material change reports or similar confidential report
with any Canadian securities regulatory authority that is still
maintained on a confidential basis.
(q) The
issue and sale of the Shares, the compliance by the Company with
this Agreement and the consummation of the transactions herein
contemplated do not and will not (i) conflict with or result in a
breach or violation of any of the terms and provisions of, or
constitute a default (or an event which with notice or lapse of
time, or both, would constitute a default) under, or result in the
creation or imposition of any Lien upon any property or assets of
the Company or any Subsidiary pursuant to, any indenture, mortgage,
deed of trust, loan agreement or other agreement, instrument,
franchise, license or permit to which the Company or any Subsidiary
is a party or by which the Company or any Subsidiary or their
respective properties, operations or assets may be bound or (ii)
violate or conflict with any provision of the certificate or
articles of incorporation, by-laws, certificate of formation,
limited liability company agreement, partnership agreement or other
organizational documents of the Company or any Subsidiary, or (iii)
violate or conflict with any statute, law, rule, regulation,
ordinance, directive, judgment, decree or order of any judicial,
regulatory or other legal or governmental agency or body, domestic
or foreign, except (in the case of clauses (i) and (iii) above) as
could not reasonably be expected to have a Material Adverse
Effect.
(r) No
Consent of, with or from any judicial, regulatory or other legal or
governmental agency or body, domestic or foreign, is required for
the execution, delivery and performance of this Agreement or
consummation of the transactions contemplated by this Agreement,
except the registration under the Securities Act of the Shares and
the qualification of the Shares for distribution in the Province of
Ontario as contemplated by this Agreement, necessary approvals of
the Toronto Stock Exchange (the " TSX ") and the NYSE Amex
LLC (" NYSE Amex ") and any consents as may be required
under state or foreign securities or blue sky laws, or the by-laws
and rules of the Financial Industry Regulatory Authority, Inc. ("
FINRA ") in connection with the purchase and distribution of
the Shares by the Underwriters.
(s) Except
as disclosed in the Registration Statement, the Pricing
Prospectuses and the Prospectuses, there is no judicial,
regulatory, arbitral or other legal or governmental proceeding or
other litigation or arbitration, U.S., Canadian or foreign, pending
to which the Company or any Subsidiary is a party or of which any
property, operations or assets of the Company or any Subsidiary is
the subject which, individually or in the aggregate, if determined
adversely to the Company or any Subsidiary, could reasonably be
expected to have a Material Adverse Effect; to the Company's
knowledge, no such proceeding, litigation or arbitration is
threatened or contemplated, which, individually or in the
aggregate, if determined adversely to the Company or any
Subsidiary, could reasonably be expected to have a Material
Adverse Effect.
(t) The
consolidated financial statements, including the notes thereto, and
the supporting schedules included or incorporated by reference in
the Registration Statement, the Pricing Prospectuses and the
Prospectuses present fairly, in all material respects, the
financial position as of the dates indicated and the cash flows and
results of operations for the periods specified of the Company and
its consolidated Subsidiaries; except as otherwise stated in the
Registration Statement, the Pricing Prospectuses and the
Prospectuses, said consolidated financial statements have been
prepared in conformity with United States generally accepted
accounting principles applied on a consistent basis throughout the
periods involved and the supporting schedules included in the
Registration Statement, the Pricing Prospectuses and the
Prospectuses present fairly, in all material respects, the
information required to be stated therein. No other
financial statements or supporting schedules are required to be
included in the Registration Statement, the Pricing
Prospectuses and the Prospectuses by Canadian Securities Laws, the
Securities Act, the Exchange Act or the Rules and
Regulations. The other financial and statistical
information included or incorporated by reference in the
Registration Statement, the Pricing Prospectuses and the
Prospectuses, including the selected consolidated financial data
set forth under the captions "Selected consolidated financial data"
and "Capitalization" in the Pricing Prospectuses and the
Prospectuses, present fairly in all material respects the
information included therein and have been prepared on a basis
consistent with that of the financial statements that are included
or incorporated by reference in the Registration Statement, the
Pricing Prospectuses and the Prospectuses and the books and records
of the Company.
(u) There
has not been any reportable event (within the meaning of National
Instrument 51-102 – Continuous Disclosure Obligations of the
Canadian Securities Administrators) between the Company and its
auditors.
(v) The
statistical, industry-related and market-related data included in
the Registration Statement, the Pricing Prospectuses and the
Prospectuses is based on or derived from sources which the
Company reasonably and in good faith believes are reliable and
accurate in all material respects, and such data agrees with the
sources from which it is derived.
(w) The
Common Stock has been registered pursuant to Section 12(b) of the
Exchange Act. The Common Stock is listed on the TSX and
the NYSE Amex, the Company is not in default of any listing
requirements of the TSX or the NYSE Amex applicable to the Company,
and the Company has taken no action designed to terminate, or
reasonably likely to have the effect of terminating, the
registration of the Common Stock under the Exchange Act or
designed to de-list, or reasonably likely to have the effect of
de-listing, the Common Stock from the TSX or the NYSE Amex, nor has
the Company received any notification that the Commission, the
Canadian Qualifying Authority, the TSX or the NYSE Amex is
contemplating terminating such registration or listing, as
applicable.
(x) The
Company and its Subsidiaries maintain a system of internal
accounting and other controls sufficient to provide reasonable
assurances that (i) transactions are executed in accordance with
management's general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial
statements in conformity with United States generally accepted
accounting principles and to maintain accountability for assets,
(iii) access to assets is permitted only in accordance with
management's general or specific authorization, and (iv) the
recorded accounting for assets is compared with existing assets at
reasonable intervals and appropriate action is taken with respect
to any differences. The books and records of the Company
and each of the Subsidiaries disclose all of their material
financial transactions and such transactions have been fairly and
accurately recorded.
(y) The
Company maintains a system of internal control over financial
reporting (as such term is defined in Rule 13a-15(f) under the
Exchange Act) that complies with the requirements of the Exchange
Act and has been designed by the Company's principal executive
officer and principal financial officer, or under their
supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with United States
generally accepted accounting principles. The Company's and its
Subsidiaries' internal control over financial reporting is
effective and the Company and its Subsidiaries are not aware of any
material weaknesses in their internal control over financial
reporting. Since the date of the latest audited consolidated
financial statements included or incorporated by reference in the
Pricing Prospectuses and the Prospectuses there has been no change
in the Company's internal control over financial reporting that has
materially affected, or is reasonably likely to materially affect,
the Company's internal control over financial reporting.
(z) The
Company maintains disclosure controls and procedures (as such term
is defined in Rule 13a-15(e) under the Exchange Act) that
comply with the requirements of the Exchange Act; such
disclosure controls and procedures have been designed to ensure
that material information relating to the Company and its
Subsidiaries is made known to the Company's principal executive
officer and principal financial officer by others within those
entities. Such disclosure controls and procedures are
effective.
(aa) There
is and has been no failure on the part of the Company or any of its
directors or officers, in their capacities as such, to
comply in all material respects with any provision of the
Sarbanes-Oxley Act of 2002 and the rules and regulations
promulgated in connection therewith, including, without limitation,
Section 402 related to loans and Sections 302 and 906 related to
certifications. Neither the Company nor any of the
Subsidiaries is indebted to any of its directors or officers, other
than on account of directors fees or expenses accrued but not paid,
or to the best of its knowledge, to any of its
stockholders. The Company has not guaranteed or agreed
to guarantee any debt, liability or other obligation of any kind
whatsoever of any person, firm or corporation of any kind
whatsoever other than of a Subsidiary.
(bb) Neither
the Company nor any of its affiliates (within the meaning of
Rule 144 under the Securities Act) has taken, directly or
indirectly, any action which constitutes or is designed to cause or
result in, or which could reasonably be expected to constitute,
cause or result in, the stabilization or manipulation of the price
of any security to facilitate the sale or resale of the
Shares.
(cc) Neither
the Company nor any of its affiliates (within the meaning of
Rule 144 under the Securities Act) has, prior to the date hereof,
made any offer or sale of any securities which could be
"integrated" (within the meaning of the Securities Act and the
Rules and Regulations) with the offer and sale of the Shares
pursuant to the Registration Statement.
(dd) The
statements set forth in the Pricing Prospectuses and the
Prospectuses under the caption "Description of Common Stock",
insofar as they purport to constitute a summary of the terms of the
Common Stock, under the caption "Underwriting", insofar as they
purport to constitute a summary of the terms of the Underwriting
Agreement, and under the caption "Material United States Federal
Income Tax Considerations for Non-U.S. Holders", insofar as they
purport to describe the provisions of the laws referred to therein,
and in the Canadian Pricing Prospectus and the Canadian Prospectus
under "Purchasers' Statutory Rights", insofar as they purport to
describe the provisions of the laws referred to therein, are
accurate and fair in all material respects.
(ee) The
Company is not registered and, upon consummation of the
transactions contemplated by this Agreement, and after giving
effect to application of the net proceeds of the Offering as
described in the Pricing Prospectuses and the Prospectuses, will
not be required to register as an "investment company" under the
Investment Company Act of 1940, as amended, and is not and will not
be an entity "controlled" by an "investment company" within the
meaning of such act.
(ff) Except
as disclosed in the Pricing Prospectuses and the Prospectuses,
there are no contracts, agreements or understandings between the
Company and any person that would give rise to a valid claim
against the Company or any Underwriter for a brokerage
commission, finder's fee or other like payment in connection with
the transactions contemplated by this Agreement.
(gg) Except
as disclosed in the Pricing Prospectuses and the Prospectuses,
neither the Company nor any of its Subsidiaries (i) has any
material lending or other relationship with any bank or lending
affiliate of any of the Underwriters or (ii) intends to use any of
the proceeds from the sale of the Shares hereunder to repay any
outstanding debt owed to any affiliate of any of the
Underwriters.
(hh) The
Company and each Subsidiary owns or leases all such properties
as are necessary to the conduct of its business as presently
operated and as proposed to be operated as described in the Pricing
Prospectuses and the Prospectuses. The Company and the
Subsidiaries have good and marketable title to all real property
and good and marketable title to all personal property owned by
them, in each case free and clear of any and all Liens except such
as are described in the Pricing Prospectuses and the
Prospectuses or such as do not (individually or in the
aggregate) materially affect the value of such property or
materially interfere with the use made or proposed to be made of
such property by the Company and the Subsidiaries; and any real
property and buildings held under lease or sublease by the Company
and the Subsidiaries are held by them under valid, subsisting and
enforceable leases with such exceptions as are not material to, and
do not materially interfere with, the use made and proposed to be
made of such property and buildings by the Company and
the Subsidiaries. Neither the Company nor any Subsidiary
has received any notice of any claim materially adverse to its
ownership of any real or personal property or of any claim against
the continued possession of any real property, whether owned or
held under lease or sublease by the Company or
any Subsidiary.
(ii) All
interests in material mining claims, concessions, exploitation or
extraction rights or similar rights (" Mining Claims ") that
are held by the Company or any of its Subsidiaries are
completely and accurately described in all material respects in the
Pricing Prospectuses and the Prospectuses and are in good standing,
are valid and enforceable, are free and clear of any material liens
or charges, and no material royalty is payable in respect of any of
them, except as disclosed in the Pricing Prospectuses and the
Prospectuses. Except as disclosed in the Pricing
Prospectuses and the Prospectuses, no other material property
rights are necessary for the conduct of the Company's business as
described therein, and there are no material restrictions on the
ability of the Company and its Subsidiaries to use, transfer or
otherwise exploit any such property rights except as required by
applicable law and the Company does not know of any claim or basis
for a claim that may adversely affect the Company's or any
Subsidiary's rights in any material respect. Except as
disclosed in the Pricing Prospectuses and the Prospectuses, the
Mining Claims held by the Company or its Subsidiaries cover
the properties required by the Company for the purposes described
in the Pricing Prospectuses and the Prospectuses.
(jj) Except
as disclosed in the Pricing Prospectuses and the Prospectuses, the
information relating to estimates by the Company of
the measured, indicated and inferred resources associated with
its mineral property projects contained in the Pricing Prospectuses
and the Prospectuses has been prepared in all material respects in
accordance with National Instrument 43-101- Standards of Disclosure
for Mineral Projects (" NI 43-101 "). The Company
believes that all of the assumptions underlying such resource
estimates are reasonable and appropriate, and that the
projected results relating to its projects and summarized in
the Pricing Prospectuses and the Prospectuses are achievable by the
Company. The Company has duly filed with the applicable
regulatory authorities all reports required by NI 43-101, and all
such reports comply with the requirements of such instrument in all
material respects.
(kk) The
Company and the Subsidiaries maintain insurance in such
amounts and covering such risks as is customary for companies
engaged in similar businesses in similar industries, all of which
insurance is in full force and effect, except where the failure to
maintain such insurance could not reasonably be expected to have a
Material Adverse Effect. There are no material claims by
the Company or any Subsidiary under any such policy or
instrument as to which any insurance company is denying liability
or defending under a reservation of rights clause. The
Company reasonably believes that it will be able to renew its
existing insurance as and when such coverage expires or will be
able to obtain replacement insurance adequate for the conduct of
the business and the value of its properties at a cost that would
not have a Material Adverse Effect.
(ll) The
Company and each of its Subsidiaries has filed all applicable
foreign, federal, state and local tax returns that are required to
be filed or has requested extensions thereof (except in any case in
which the failure so to file would not have a Material Adverse
Effect), and has paid all taxes required to be paid by it and any
other assessment, fine or penalty levied against it, to the extent
that any of the foregoing is due and payable, except for any such
assessment, fine or penalty that is currently being contested in
good faith or as would not have a Material Adverse
Effect.
(mm) There
are no transfer taxes or other similar fees or charges under
Canadian or U.S. federal law or the laws of any state, province or
any political subdivision thereof, required to be paid in
connection with the execution and delivery of this Agreement or the
issuance by the Company or sale by the Company of the
Shares.
(nn)
No dispute between the Company and any local, native or indigenous
group exists or, to the Company's knowledge, is threatened or
imminent with respect to any of the Company's properties or
exploration activities that could reasonably be expected to have a
Material Adverse Effect.
(oo)
No labor disturbance by the employees of the Company or
any Subsidiary exists or, to the Company's knowledge, is
imminent and the Company is not aware of any existing or imminent
labor disturbances by the employees of any of its or any
Subsidiary's principal suppliers, manufacturers, customers or
contractors, which, in either case (individually or in the
aggregate), could reasonably be expected to have a Material Adverse
Effect.
(pp)
No "prohibited transaction" (as defined in either Section 406 of
the Employee Retirement Income Security Act of 1974, as amended,
including the regulations and published interpretations thereunder
(" ERISA "), or Section 4975 of the Internal Revenue Code of
1986, as amended from time to time (the " Code ")), or
"accumulated funding deficiency" (as defined in Section 302 of
ERISA) or other event covered by Section 4043(b) of ERISA (other
than events with respect to which the 30-day notice requirement
under Section 4043 of ERISA has been waived) has occurred with
respect to any employee benefit plan subject to ERISA or the Code
for which the Company or any Subsidiary would have any liability
which could (individually or in the aggregate) reasonably be
expected to have a Material Adverse Effect; each employee benefit
plan for which the Company or any Subsidiary would have any
liability is in compliance in all material respects with applicable
law, including (without limitation) ERISA and the Code; the Company
has not incurred and does not expect to incur liability under Title
IV of ERISA with respect to the termination of, or withdrawal from,
any "pension plan" within the meaning of Section 3(2) of ERISA; and
each plan for which the Company would have any liability that is
intended to be qualified under Section 401(a) of the Code is so
qualified and nothing has occurred, whether by action or by failure
to act, which could cause the loss of such
qualification.
(qq) There
has been no storage, generation, transportation, handling, use,
treatment, disposal, discharge, emission, contamination, release or
other activity involving any kind of hazardous, toxic or other
wastes, pollutants, contaminants, petroleum products or other
hazardous or toxic substances, chemicals or materials ("
Hazardous Substances ") by or on behalf of the Company or
any Subsidiary (or, to the Company's knowledge, any other entity
for whose acts or omissions the Company is or may be liable) upon
any property now or previously owned, operated, used or leased by
the Company or any Subsidiary which would be a violation of or give
rise to any liability under any applicable law, rule, regulation,
order, judgment, decree or permit, common law provision or other
legally binding standard relating to pollution or protection of
human health and the environment (" Environmental Law "),
except for violations and liabilities which, individually or in the
aggregate, could not reasonably be expected to have a Material
Adverse Effect. Neither the Company nor any Subsidiary
has agreed to assume, undertake or provide indemnification for any
liability of any other person under any Environmental Law,
including any obligation for cleanup or remedial action, except as
could not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect. There is no pending or, to
the Company's knowledge, threatened administrative, regulatory or
judicial action, claim or notice of noncompliance or violation,
investigation or proceedings relating to any Environmental Law
against the Company or any Subsidiary which, individually or in the
aggregate, if determined adversely to the Company or any
Subsidiary, could reasonably be expected to have a Material Adverse
Effect. Neither the Company nor any Subsidiary is
subject to any order, decree, agreement or other individualized
legal requirement related to any Environmental Law, which, in any
case (individually or in the aggregate), could reasonably be
expected to have a Material Adverse Effect.
(rr) In
the ordinary course of its business, the Company periodically
reviews the effect of Environmental Laws on the business,
operations and properties of the Company and its Subsidiaries, in
the course of which it identifies and evaluates associated costs
and liabilities (including, without limitation, any capital or
operating expenditures required for clean-up, closure or
remediation of properties or compliance with Environmental Laws, or
any permit, license or approval, any related constraints on
operating activities and any potential liabilities to third
parties). On the basis of such review, the Company has
reasonably concluded that such associated costs and liabilities so
far as they relate to matters known to the Company as of the date
of this Agreement would not, individually or in the aggregate, have
a Material Adverse Effect.
(ss) None
of the Company, any Subsidiary or, to the Company's knowledge, any
of its employees or agents, has at any time during the last five
years (i) made any unlawful contribution to any candidate for
non-United States office, or failed to disclose fully any such
contribution in violation of law, or (ii) made any payment to any
federal or state governmental officer or official, or other person
charged with similar public or quasi-public duties, other than
payments required or permitted by the laws of the United States of
any jurisdiction thereof. The operations of the Company
and each Subsidiary are and have been conducted at all times in
material compliance with applicable financial record-keeping and
reporting requirements of the Currency and Foreign Transactions
Reporting Act of 1970, as amended, the money laundering statutes of
all applicable jurisdictions, the rules and regulations thereunder
and any related or similar rules, regulations or guidelines issued,
administered or enforced by any governmental agency (collectively,
the " Money Laundering Laws ") and no action, suit or
proceeding by or before any court or governmental agency, authority
or body or any arbitrator involving the Company or any Subsidiary
with respect to the Money Laundering Laws is pending or, to the
best knowledge of the Company, threatened. Neither the
Company nor any Subsidiary nor, to the knowledge of the Company,
any director, officer, agent, employee or affiliate of the Company
or any Subsidiary is currently subject to any U.S. sanctions
administered by the Office of Foreign Assets Control of the U.S.
Treasury Department (" OFAC "); and the Company will not
directly or indirectly use the proceeds of the Offering, or lend,
contribute or otherwise make available such proceeds to any
Subsidiary, joint venture partner or other person or entity, for
the purpose of financing the activities of any person currently
subject to any U.S. sanctions administered by OFAC.
(tt) Neither
the Company nor any Subsidiary (i) is in violation of its
certificate or articles of incorporation, by-laws, certificate of
formation, limited liability company agreement, partnership
agreement or other organizational documents, (ii) is in default
under, and no event has occurred which, with notice or lapse of
time or both, would constitute a default under or result in the
creation or imposition of any Lien upon any property or assets of
the Company or any Subsidiary pursuant to, any indenture,
mortgage, deed of trust, loan agreement or other agreement or
instrument to which it is a party or by which it is bound or to
which any of its property or assets is subject, or (iii) is in
violation of any statute, law, rule, regulation, ordinance,
directive, judgment, decree or order of any judicial, regulatory or
other legal or governmental agency or body, U.S., Canadian or
foreign, except (in the case of clauses (ii) and (iii) above) for
violations or defaults that could not (individually or in the
aggregate) reasonably be expected to have a Material Adverse
Effect.
(uu) The
Company has complied in all material respects with the requirements
of Rule 433 under the Securities Act with respect to each Issuer
Free Writing Prospectus including, without limitation, all
prospectus delivery, filing, record retention and legending
requirements applicable to any such Issuer Free Writing
Prospectus. The Company has not (i) distributed any
offering material in connection with the Offering other than the
Pricing Prospectuses, the Prospectuses and any Issuer Free Writing
Prospectus set forth on Annex V hereto, or (ii) filed, referred to,
approved, used or authorized the use of any "free writing
prospectus" as defined in Rule 405 under the Securities Act with
respect to the Offering or the Shares, except for any Issuer Free
Writing Prospectus set forth in Annex V hereto and
any electronic road show previously approved by the Lead
Manager.
(vv) The
Company is a reporting issuer in the Province of Ontario and is not
in default of any requirements of Canadian Securities
Law.
(ww) Mellon
Investor Services LLC at its principal offices in the City of
Denver, Colorado is the duly appointed registrar and transfer agent
of the Company with respect to the Common Stock, and CIBC Mellon at
its principal offices in the City of Toronto, Ontario is the duly
appointed co-transfer agent of the Company with respect to the
Common Stock.
(xx) The
minute books and corporate records of the Company and
its Subsidiaries contain true and correct copies of all
minutes of all meetings and all resolutions of the directors (and
any committees of such directors) and stockholders of the Company
and its Subsidiaries as at the date hereof and at the Closing
Date will contain the minutes of all meetings and all resolutions
of the directors (and any committees of such directors) and
stockholders of the Company and its Subsidiaries.
(yy) Each
stock option granted under any stock option plan of the Company or
any Subsidiary (each, a " Stock Plan ") was granted with a
per share exercise price no less than the fair market value per
share of Common Stock on the grant date of such option, and no such
grant involved any "back-dating," "forward-dating" or similar
practice with respect to the effective date of such grant; each
such option (i) was granted in material compliance with applicable
law and with the applicable Stock Plan(s), (ii) was duly approved
by the board of directors (or a duly authorized committee thereof)
of the Company or such Subsidiary, as applicable, and (iii) has
been properly accounted for in the Company's financial statements
and disclosed, to the extent required, in the Company's filings or
submissions with the Commission and the Canadian Qualifying
Authority.
Any certificate signed by or on behalf of the
Company and delivered to the Lead Manager or to counsel for the
Underwriters shall be deemed to be a representation and warranty by
the Company to each Underwriter as to the matters covered
thereby.
2. Purchase, Sale
and Delivery of the Shares .
(a) On
the basis of the representations, warranties, covenants and
agreements herei
|